"Pyruvate Kinase/blood"[MeSH] - Search Results

Year	Number of Results
1964	1
1965	1
1966	8
1967	17
1968	31
1969	19
1970	26
1971	30
1972	44
1973	28
1974	44
1975	38
1976	36
1977	34
1978	17
1979	28
1980	27
1981	23
1982	23
1983	30
1984	29
1985	21
1986	16
1987	27
1988	13
1989	20
1990	20
1991	19
1992	7
1993	8
1994	8
1995	7
1996	6
1997	8
1998	4
1999	9
2000	11
2001	4
2002	3
2003	11
2004	8
2005	5
2006	2
2007	11
2008	10
2009	1
2010	5
2011	3
2012	4
2013	4
2014	4
2015	4
2016	4
2017	5
2018	9
2019	4
2020	5
2021	3
2022	2
2024	0

1

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.

Watanabe R, Hashimoto M. Watanabe R, et al. Rheumatology (Oxford). 2022 Jul 6;61(7):e183-e184. doi: 10.1093/rheumatology/keac092. Rheumatology (Oxford). 2022. PMID: 35166773 No abstract available.

2

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply.

Esen I, Jiemy WF, van Sleen Y, Reitsema RD, Bijzet J, de Jong DM, Nienhuis PH, Slart RHJA, Heeringa P, Boots AMH, Brouwer E. Esen I, et al. Rheumatology (Oxford). 2022 Jul 6;61(7):e185-e187. doi: 10.1093/rheumatology/keac093. Rheumatology (Oxford). 2022. PMID: 35166769 Free PMC article. No abstract available.

3

Pyruvate kinase deficiency: the genotype-phenotype association.

Zanella A, Fermo E, Bianchi P, Chiarelli LR, Valentini G. Zanella A, et al. Blood Rev. 2007 Jul;21(4):217-31. doi: 10.1016/j.blre.2007.01.001. Epub 2007 Mar 13. Blood Rev. 2007. PMID: 17360088 Review.

4

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.

Kumar Y, Tapuria N, Kirmani N, Davidson BR. Kumar Y, et al. Eur J Gastroenterol Hepatol. 2007 Mar;19(3):265-76. doi: 10.1097/MEG.0b013e3280102f78. Eur J Gastroenterol Hepatol. 2007. PMID: 17301655 Review.

5

Cord blood transplantation in a young child with pyruvate kinase deficiency.

Akiyoshi K, Sekiguchi K, Okamoto T, Suenobu S, Izumi T. Akiyoshi K, et al. Pediatr Int. 2016 Jul;58(7):634-6. doi: 10.1111/ped.12889. Epub 2016 Mar 8. Pediatr Int. 2016. PMID: 27460399

6

Pyruvate kinase M2 and its evolving role as a prognostic marker in systemic malignancies besides colorectal carcinomas.

Kapoor S. Kapoor S. Tumour Biol. 2013 Feb;34(1):611. doi: 10.1007/s13277-012-0528-7. Epub 2012 Oct 4. Tumour Biol. 2013. PMID: 23055193 No abstract available.

7

Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy.

Hathurusinghe HR, Goonetilleke KS, Siriwardena AK. Hathurusinghe HR, et al. Ann Surg Oncol. 2007 Oct;14(10):2714-20. doi: 10.1245/s10434-007-9481-x. Epub 2007 Jun 30. Ann Surg Oncol. 2007. PMID: 17602267 Review.

8

Pyruvate kinase deficiency.

Miwa S. Miwa S. Prog Clin Biol Res. 1990;344:843-52. Prog Clin Biol Res. 1990. PMID: 2203063 Review.

9

Plasma Tumor M2-Pyruvate Kinase Levels in Different Cancer Types.

Muñoz-Colmenero A, Fernández-Suárez A, Fatela-Cantillo D, Ocaña-Pérez E, Domínguez-Jiménez JL, Díaz-Iglesias JM. Muñoz-Colmenero A, et al. Anticancer Res. 2015 Jul;35(7):4271-6. Anticancer Res. 2015. PMID: 26124389

10

Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer.

Xu C, Liu W, Li L, Wang Y, Yuan Q. Xu C, et al. J Cell Mol Med. 2021 Aug;25(15):7335-7341. doi: 10.1111/jcmm.16762. Epub 2021 Jul 13. J Cell Mol Med. 2021. PMID: 34255923 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

836 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

836 results

Results by year